Cincinnati.com: Should I get one of the new COVID-19 boosters?
UC expert says it's best to get boosted before winter
The new booster vaccines to protect against severe COVID-19 have been authorized for use, and they come with the bonus of extra protection against the omicron variants that have been infecting people for months.
The U.S. Food and Drug Administration authorized the Pfizer BioNTech and Moderna boosters on Aug. 31 and the Centers for Disease Control and Prevention followed with approval the following day.
They're called bivalent vaccines because they target two strains of the virus, the original, which all previous vaccines have protected against, and the omicron subvariants BA.4 and BA.5.
Cincinnati.com checked with local experts on COVID-19 boosters, including Carl Fichtenbaum, MD, of the Division of Infectious Diseases in the Department of Internal Medicine at the UC College of Medicine.
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Colleen Kelley/UC Marketing + Brand
The experts cited by Cincinnati.com said the sooner you can get a booster shot the better, and to at least get it done before winter.
"It's best to do this from September to November, in approach of the cold and flu season," said Fichtenbaum.
Fichtenbaum listed a range of ways boosters protect communities.
- They help ensure fewer lost work and school days.
- They prevent economic losses.
- They mean fewer hospitalizations for respiratory-related illnesses during cold and flu season.
"When you add this booster to prior vaccination and prior infection immunity," he said, "there will be a lot more protection in the community against COVID."
Fichtenbaum was also interviewed about COVID-19 boosters on Cincinnati Edition on WVXU. Hear that interview here.
Lead photo/Colleen Kelley/UC Marketing + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.